Literature DB >> 11967151

A murine model of Nijmegen breakage syndrome.

Bret R Williams1, Olga K Mirzoeva, William F Morgan, Junyu Lin, Wesley Dunnick, John H J Petrini.   

Abstract

Nijmegen breakage syndrome (NBS) is a rare autosomal recessive disorder characterized by microcephaly, immunodeficiency, and predisposition to hematopoietic malignancy. The clinical and cellular phenotypes of NBS substantially overlap those of ataxia-telangiectasia (A-T). NBS is caused by mutation of the NBS1 gene, which encodes a member of the Mre11 complex, a trimeric protein complex also containing Mre11 and Rad50. Several lines of evidence indicate that the ataxia-telangiectasia mutated (ATM) kinase and the Mre11 complex functionally interact. Both NBS and A-T cells exhibit ionizing radiation (IR) sensitivity and defects in the intra S phase checkpoint, resulting in radioresistant DNA synthesis (RDS)-the failure to suppress DNA replication origin firing after IR exposure. NBS1 is phosphorylated by ATM in response to IR, and this event is required for activation of the intra S phase checkpoint (the RDS checkpoint). We derived a murine model of NBS, the Nbs1(DeltaB/DeltaB) mouse. Nbs1(DeltaB/DeltaB) cells are phenotypically identical to those established from NBS patients. The Nbs1(DeltaB) allele was synthetically lethal with ATM deficiency. We propose that the ATM-Mre11 complex DNA damage response pathway is essential and that ATM or the Mre11 complex serves as a nexus to additional components of the pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11967151     DOI: 10.1016/s0960-9822(02)00763-7

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  80 in total

Review 1.  The cellular control of DNA double-strand breaks.

Authors:  Shaun P Scott; Tej K Pandita
Journal:  J Cell Biochem       Date:  2006-12-15       Impact factor: 4.429

Review 2.  The multiple roles of the Mre11 complex for meiotic recombination.

Authors:  Valérie Borde
Journal:  Chromosome Res       Date:  2007       Impact factor: 5.239

3.  Genome maintenance defects in cultured cells and mice following partial inactivation of the essential cell cycle checkpoint gene Hus1.

Authors:  Peter S Levitt; Min Zhu; Amy Cassano; Stephanie A Yazinski; Houchun Liu; Joshua Darfler; Rachel M Peters; Robert S Weiss
Journal:  Mol Cell Biol       Date:  2007-01-12       Impact factor: 4.272

4.  Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS.

Authors:  Erin R P Shull; Youngsoo Lee; Hironobu Nakane; Travis H Stracker; Jingfeng Zhao; Helen R Russell; John H J Petrini; Peter J McKinnon
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

5.  BRCA2 is required for neurogenesis and suppression of medulloblastoma.

Authors:  Pierre-Olivier Frappart; Youngsoo Lee; Jayne Lamont; Peter J McKinnon
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

Review 6.  DNA strand breaks, neurodegeneration and aging in the brain.

Authors:  Sachin Katyal; Peter J McKinnon
Journal:  Mech Ageing Dev       Date:  2008-03-25       Impact factor: 5.432

Review 7.  Mouse models of DNA double-strand break repair and neurological disease.

Authors:  Pierre-Olivier Frappart; Peter J McKinnon
Journal:  DNA Repair (Amst)       Date:  2008-05-23

Review 8.  The Nijmegen breakage syndrome gene and its role in genome stability.

Authors:  Kenta Iijima; Kenshi Komatsu; Shinya Matsuura; Hiroshi Tauchi
Journal:  Chromosoma       Date:  2004-07-17       Impact factor: 4.316

9.  DNA damage signaling in hematopoietic cells: a role for Mre11 complex repair of topoisomerase lesions.

Authors:  Monica Morales; Yan Liu; Evagelia C Laiakis; William F Morgan; Stephen D Nimer; John H J Petrini
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

10.  Cancer predisposition and hematopoietic failure in Rad50(S/S) mice.

Authors:  Carla F Bender; Michael L Sikes; Ruth Sullivan; Leslie Erskine Huye; Michelle M Le Beau; David B Roth; Olga K Mirzoeva; Eugene M Oltz; John H J Petrini
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.